# BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects

> **NCT06275464** · PHASE1 · COMPLETED · sponsor: **Biora Therapeutics, Inc.** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **COMBINATION_PRODUCT:** BT-600
- **COMBINATION_PRODUCT:** BT-600 Placebo

## Key facts

- **NCT ID:** NCT06275464
- **Lead sponsor:** Biora Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-11
- **Primary completion:** 2024-04-18
- **Final completion:** 2024-04-23
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-11-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06275464

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06275464, "BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06275464. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*